Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 21 - Number 8

Review Article

Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression

, 21(8): 631 - 639

Juan Zhou, Jing Zhao and Chunxia Su*

DOI: 10.2174/1568009619666210316112333

Review Article

Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy

, 21(8): 640 - 665

Milad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, Vahideh Zarrin, Kiavash Hushmandi, Farid Hashemi, Anuj Kumar, Saeed Samarghandian, Masoud Najafi* and Ali Zarrabi*

DOI: 10.2174/1568009621666210203110305

Review Article

Role of Exosomes in Breast Cancer Management: Evidence-Based Review

, 21(8): 666 - 675

Razan B. Al-Humaidi, Bahgat Fayed, Suleiman I. Sharif, Ayman Noreddin and Sameh S.M. Soliman*

DOI: 10.2174/1568009621666210601115707

Review Article

The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer

, 21(8): 676 - 688

Sara Memarpour*, Ghazaleh Khalili-Tanha*, Awa Alizadeh Ghannad, Masoud Sharifian Razavi, Mona Joudi, Marjan Joodi, Gordon A. Ferns, Seyed Mahdi Hassanian, Majid Khazaei and Amir Avan*

DOI: 10.2174/1568009621666210311090531

Review Article

New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles

, 21(8): 689 - 701

Keyvan Khazei, Nasrin Mohajeri, Esat Bonabi, Zeynep Turk and Nosratollah Zarghami *

DOI: 10.2174/1568009621666210525152802

Research Article

MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX1

, 21(8): 702 - 712

Tongqing Xue, Gang Yin, Weixuan Yang, Xiaoyu Chen, Cheng Liu, Weixi Yang* and Jun Zhu*

DOI: 10.2174/1568009621666210415094350

Research Article

NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting HIF1A in NONO-TFE3 Translocation Renal Cell Carcinoma

, 21(8): 713 - 723

Yi Chen, Lei Yang, Ning Liu, Qiancheng Shi, Xiaoqin Yin, Xiaodong Han, Weidong Gan* and Dongmei Li*

DOI: 10.2174/1568009621666210412115026


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog